Nocion Therapeutics: Funding, Investors & Team (Oct 2026)
Nocion Therapeutics creates innovative pharmaceuticals designed to address conditions related to neurogenic inflammation. The company is focused on developing "nocions," a unique form of therapy that specifically targets nociceptors that are actively firing. This approach allows for precise and long-lasting relief for patients suffering from various conditions such as cough, itch, pain, and inflammation.
Nocion Therapeutics has raised $85.0M across 2 funding rounds on record, the most recent a Series B of $23.0M announced in Jan 2026.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Nocion Therapeutics Company Profile and Key Stats
Latest funding round on record: Jan 2026.
Nocion Therapeutics Funding Rounds
Nocion Therapeutics raised $62.0M in an undisclosed round announced in Mar 2024.
1.8 years later, a Series B of $23.0M was announced in Jan 2026.
Nocion Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Nocion Therapeutics Funding Compared to Other Biotechnology Startups
Nocion Therapeutics' latest round of $23.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Nocion Therapeutics in Biotechnology and Cambridge
Companies Similar to Nocion Therapeutics
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Nocion Therapeutics Funding FAQs
What does Nocion Therapeutics do?
Nocion Therapeutics creates innovative pharmaceuticals designed to address conditions related to neurogenic inflammation. The company is focused on developing "nocions," a unique form of therapy that specifically targets nociceptors that are actively firing. This approach allows for precise and long-lasting relief for patients suffering from various conditions such as cough, itch, pain, and inflammation.
How much funding has Nocion Therapeutics raised?
Nocion Therapeutics has raised $85.0M across 2 rounds on record. The most recent is a Series B of $23.0M announced in Jan 2026.
When did Nocion Therapeutics last raise funding?
Nocion Therapeutics' most recent funding round on record is a Series B of $23.0M, announced in Jan 2026.
Who founded Nocion Therapeutics?
FundedIQ lists Bruce Bean (Founder), Clifford J Woolf (Founder) at Nocion Therapeutics.
Where is Nocion Therapeutics headquartered?
Nocion Therapeutics is based in Cambridge, Massachusetts, United States.
How many employees does Nocion Therapeutics have?
Nocion Therapeutics is in the 11-50 employee band.
How does Nocion Therapeutics' funding compare to other Biotechnology startups?
Nocion Therapeutics' latest round of $23.0M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Nocion Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Nocion Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.